Johnson & Johnson subsidiary DePuy Orthopedics recalls all unused custom implants, a product line the company discontinued after receiving an FDA warning letter late last year.

Following an FDA request, Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics launched a recall of all unused units of its customer orthopedic implants, a product line the company shut down in January.
Concerns that the medical device tax will push companies to lay off workers and move operations...
The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement...
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...